Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Shares Outstanding (Entity) (2023 - 2026)

Updated

Translational Development Acquisition (TDACU) recorded Shares Outstanding (Entity) of 28.62 million in Q2 2026, up 30.7% from 21.91 million a year earlier and up 30.7% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends

For FY2025, Translational Development Acquisition reported Shares Outstanding (Entity) of 21.91 million, down 15.6% from FY2024.

  • Across earlier years, Shares Outstanding (Entity) came in at 25.97 million in FY2024 (+220.6%) and 8.1 million in FY2023.
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2023.
  • On a year-over-year basis, Shares Outstanding (Entity) rose in three of the last six quarters, with growth averaging 61.9%.
  • Per Business Quant, the preceding three quarters came in at 21.91 million (Q1 2026), 21.91 million (Q4 2025) and 21.91 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.62 Mn
Mar 31, 2026 21.91 Mn
Dec 31, 2025 21.91 Mn
Sep 30, 2025 21.91 Mn
Jun 30, 2025 21.91 Mn
Mar 31, 2025 21.91 Mn
Dec 31, 2024 25.97 Mn
Sep 30, 2024 25.97 Mn
Jun 30, 2024 8.71 Mn
Dec 31, 2023 8.10 Mn
API Access

Translational Development Acquisition Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TDACU&period=max&api_key=YOUR_API_KEY